Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

FTXH vs. QAAGZX: which is better?

Bottom line

FTXH vs QAAGZX: the short answer

FTXH (First Trust Nasdaq Pharmaceuticals ETF) and QAAGZX (T. Rowe Price Health Sciences Portfolio) are both etfs.

But QAAGZX is far broader, holding 277 positions to 51 for FTXH, so beyond the top names it adds exposure FTXH doesn't have.

FTXH is cheaper at 0.6% vs 0.86% — a difference of $26 a year per $10,000 invested.

Over five years, FTXH returned +6.5% a year vs +4.1% for QAAGZX.

Updated Nov 19, 2026

FTXH vs QAAGZX side by side

FTXHQAAGZX
TypeETFETF
Fund familyFirst TrustT. Rowe Price
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.6%0.86%
Annual cost per $10k$60$86
10-yr cost on $10k (prospectus)—$1,061
Max front loadNoneNone
12b-1 fee0%0%
1-yr return+24.0%+18.1%
5-yr return (annualized)+6.5%+4.1%
10-yr return (annualized)—+9.0%
Best quarter+18.3%+23.4%
Worst quarter−17.4%−15.8%
Net assets (fund)$36.2M$751.7M
Number of holdings51277
Portfolio turnover35%65%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearFTXHQAAGZXDifference
2025+24.0%+18.1%+5.9%
2024+3.0%+1.7%+1.3%
2023−1.4%+3.0%−4.4%
2022+2.5%−12.5%+15.0%
2021+6.1%+13.1%−7.0%
2020+10.9%+29.6%−18.8%
2019+22.4%+29.0%−6.6%
2018−8.4%+1.1%−9.5%
2017+18.8%+27.6%−8.8%

Source: Fund prospectus bar charts

Holdings overlap

9 of FTXH's top 25 holdings also appear in QAAGZX's top 25.

Shared top holdings
HoldingFTXHQAAGZX
Eli Lilly & Company7.77%14.06%
Abbvie Inc7.39%5.12%
Merck & Company Inc7.07%4.00%
Johnson & Johnson6.96%6.64%
Bristol-myers Squibb Company6.29%2.12%
Cardinal Health Inc3.53%1.04%
Vertex Pharmaceuticals Inc3.41%2.26%
Amgen Inc3.18%1.80%
Gilead Sciences Inc2.89%2.79%

Source: SEC Form N-PORT

FTXH top 10

  1. Eli Lilly & Company — 7.77%
  2. Abbvie Inc — 7.39%
  3. Merck & Company Inc — 7.07%
  4. Johnson & Johnson — 6.96%
  5. Bristol-myers Squibb Company — 6.29%
  6. Biogen Inc — 3.84%
  7. Viatris Inc — 3.62%
  8. Cardinal Health Inc — 3.53%
  9. Vertex Pharmaceuticals Inc — 3.41%
  10. Amgen Inc — 3.18%

QAAGZX top 10

  1. Eli Lilly & Co — 14.06%
  2. Johnson & Johnson — 6.64%
  3. Unitedhealth Group Inc — 5.88%
  4. Abbvie Inc — 5.12%
  5. Merck & Co. Inc. — 4.00%
  6. Gilead Sciences Inc — 2.79%
  7. Thermo Fisher Scientific Inc — 2.53%
  8. Vertex Pharmaceuticals Inc — 2.26%
  9. Bristol-myers Squibb Co — 2.12%
  10. Abbott Laboratories — 1.91%

FAQ

What is the difference between FTXH and QAAGZX?
FTXH (First Trust Nasdaq Pharmaceuticals ETF) and QAAGZX (T. Rowe Price Health Sciences Portfolio) are both etfs. But QAAGZX is far broader, holding 277 positions to 51 for FTXH, so beyond the top names it adds exposure FTXH doesn't have.
Which is cheaper, FTXH or QAAGZX?
FTXH has the lower expense ratio (0.6%).
Should I own both FTXH and QAAGZX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.